Leukotrienes and Lung Inflammation
白三烯与肺部炎症
基本信息
- 批准号:7392805
- 负责人:
- 金额:$ 40.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-04 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:Alveolar MacrophagesAntigensArachidonate 5-LipoxygenaseAsthmaBiochemistryBiologicalBleomycinBone MarrowBone Marrow CellsBronchoalveolar LavageCell NucleusCellsComplexCytosolCytosolic Phospholipase A2DiseaseEicosanoidsEndotheliumFibroblastsGenerationsHamman-Rich syndromeHost DefenseHydrolaseIgEInfectionInflammationInflammatoryInflammatory ResponseKineticsLTA geneLeukocytesLeukotriene A4Leukotriene B4Leukotriene C4Leukotriene D4LeukotrienesLinkLipidsLocalizedLungLung InflammationLung diseasesMacromolecular ComplexesMembraneMetabolismMolecularMusMuscle ContractionMutationNuclearNuclear EnvelopeNuclear Inner MembraneNuclear Outer MembranePathogenesisPatientsPermeabilityPopulationProteinsPulmonary FibrosisResearch PersonnelShapesSliceTestingTherapeuticTumor Necrosis Factor-Betain vivoleukotriene-C4 synthasemacrophagemast cellmolecular imagingneutrophilnovelpreventprogramsresponse
项目摘要
DESCRIPTION (provided by applicant): Mast cells, macrophages, and polymorphonuclear leukocytes (PMN), initiate and amplify inflammation in the lung by synthesizing and releasing the bioactive lipids leukotriene (LT)B4, and LTC4. After its release from cells, LTC4 is converted to LTD4. These eicosanoids help "shape" the pulmonary inflammatory response by regulating leukocyte recruitment, endothelial permeability, fibroblast proliferation, and smooth muscle contraction. LTC4, LTD4 and LTB4 are central to the pathogenesis of asthma and idiopathic pulmonary fibrosis (IFF). They are also critical for host defense to infection. How cells modulate the synthesis of these eicosanoids is therefore central to the pathogenesis of these diseases. The formation of LTC4 requires the functional interaction of at least four proteins on the nuclear envelope. These are cytosolic phospholipase A2 (cPLA2), 5-lipoxygenase (5-LO), the 5-lipoxygenase-activating protein (FLAP), and LTC4 synthase; the metabolism of LTA by LTA4 hydrolase yields LTB4. We have used a combination of biochemistry and molecular imaging to demonstrate the interaction of 5-LO, FLAP, and LTC4 synthase in novel, activation- dependent, macromolecular complexes on the nuclear envelope that include additional proteins. We have also identified a 10 kDa protein (Associated Protein 10 kDa, AP-10) that dissociates from FLAP after cell activation concurrent with complex formation. The hypothesis of this proposal is that these complexes are the link between cell activation and LT synthesis. The broad long-term objective of this proposal is to understand how the assembly, degradation, and compartmentalization of these complexes regulate the formation of LTs on molecular, cell biological, and in vivo levels. Three Specific Aims are proposed. In Specific Aim 1 we will determine how 5-LO membrane complexes are assembled and organized. In Specific Aim 2 we will identify the AP-10 protein. In Specific Aim 3 we will test the hypothesis that the synthesis of LTC4 and LTB4 is compartmentalized between the cytosol and nucleus and that newly identified inner membrane 5-LO complexes regulate the synthesis of LTB4. The completion of these aims will allow the identification of novel mechanisms and, potentially, therapeutic approaches, to inflammatory pulmonary diseases.
描述(申请人提供):肥大细胞、巨噬细胞和多形核白细胞(PMN)通过合成和释放生物活性脂类白三烯(LT)B4和LTC4来启动和放大肺部的炎症。从细胞中释放出来后,LTC4被转化为LTD4。这些二十烷基类化合物通过调节白细胞募集、内皮通透性、成纤维细胞增殖和平滑肌收缩,帮助“塑造”肺部炎症反应。LTC4、LTD4和LTB4在哮喘和特发性肺纤维化(IFF)的发病机制中起中心作用。它们对宿主防御感染也是至关重要的。因此,细胞如何调节这些二十烷基类化合物的合成是这些疾病发病机制的核心。LTC4的形成需要核膜上至少四种蛋白质的功能相互作用。它们是胞浆磷脂酶A2(CPLA2)、5-脂氧合酶(5-LO)、5-脂氧合酶激活蛋白(FLAP)和LTC4合成酶;LTA被LTA4水解酶代谢产生LTB4。我们使用生物化学和分子成像相结合的方法来展示5-LO、FLOW和LTC4合成酶在核膜上的新型、激活依赖的大分子复合体中的相互作用,这些复合体包括额外的蛋白质。我们还鉴定了一种10 kDa的蛋白质(Association Protein 10 kDa,AP-10),它在细胞激活后与复合体形成同时从翻盖上解离。这一建议的假设是,这些复合体是细胞激活和LT合成之间的纽带。这项提议的广泛的长期目标是了解这些复合体的组装、降解和分隔是如何在分子、细胞生物学和体内水平上调节LT的形成的。提出了三个具体目标。在具体目标1中,我们将确定5-LO膜复合体是如何组装和组织的。在特定目标2中,我们将鉴定AP-10蛋白。在特定的目标3中,我们将检验这样的假设,即LTC4和LTB4的合成在胞浆和细胞核之间划分,并且新发现的内膜5-LO复合体调节LTB4的合成。这些目标的完成将使我们能够确定炎症性肺部疾病的新机制,并可能找到治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roy Soberman其他文献
Roy Soberman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roy Soberman', 18)}}的其他基金
Role of B7-1 in Podocytes in Pathogenesis of Proteinuria
足细胞 B7-1 在蛋白尿发病机制中的作用
- 批准号:
9322522 - 财政年份:2004
- 资助金额:
$ 40.04万 - 项目类别:
Role of B7-1 in Podocytes in Pathogenesis of Proteinuria
足细胞 B7-1 在蛋白尿发病机制中的作用
- 批准号:
8895921 - 财政年份:2004
- 资助金额:
$ 40.04万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 40.04万 - 项目类别:
Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 40.04万 - 项目类别:
Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 40.04万 - 项目类别:
Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 40.04万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 40.04万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 40.04万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 40.04万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 40.04万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 40.04万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 40.04万 - 项目类别: